Revolutionizing Microbial Technology

Unlocking the Potential of Artificial Intelligence
Erscheinungsjahr 2026
ISBN: 978-0-443-40362-0
Verlag: Elsevier Science

Buch, Englisch, 384 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 450 g

Revolutionizing Microbial Technology: Unlocking the Potential of Artificial Intelligence explores the potential integration of artificial intelligence (AI) and machine learning in the fields of microbiology and biotechnology. The book delves into various applications of AI in microbiology across different sectors. This includes coverage of basic microbiology, identification and characterization of microbes, how AI can be implemented in microbiology laboratory practices, and how bioinformatics can help analyze microbial data and help understand complex biological systems. It discusses implementation of AI in healthcare for the diagnosis of microbial diseases and AI-driven microbial therapies and examines potential AI solutions for the acceleration, cost-effectiveness, and efficiency of the drug discovery and drug development process. Additional coverage includes the AI integration in the food and agricultural industries. Revolutionizing Microbial Technology provides a comprehensive understanding to researchers, academics, industry professionals and students of the potential of AI as an advance tool for microbial research and application.

Autoren/Hrsg.

Srivastava, Akanksha

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer
• Naturwissenschaften Biowissenschaften Mikrobiologie
• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Biotechnologie

Inhaltsverzeichnis

1. Development of molecular tools for the mass production of microbial metabolites
2. Uncovering Extended Functions of Artificial Intelligence in the Mass Production of Microbial Metabolites
3. AI-Driven Insights into Phage-Host Dynamics: Antimicrobial Stewardship in Reaching the Right Target
4. Enhancing food quality, processing and preservation through AI and microbiological interventions
5. AI-Driven Molecular Strategies for Scalable Microbial Metabolite Production
6. Decoding Phages: The Role of Artificial Intelligence in Bacteriophage Science
7. AI's Diagnostic Revolution: A One Health Approach to Zoonotic Infections: Speed, Accuracy, and Precision in Infectious Disease Detection
8. Artificial Intelligence Versus AMR: Intelligent Solutions against Drug-Resistant Infections
9. Explore the scientific implications of microbial gene editing technologies (e.g., CRISPR via AI)
10. Efficient and Cost-Effective Production of Viral Vaccibes VIA AI
11. Environmental Microbiology in the Age of Nanotechnology and AI: Advancing Microbial Technologies for a Sustainable Future
12. AI Implementation in bioreactor design and optimization of the fermentation conditions for microbial metabolite production
13. Integrating Artificial Intelligence and CRISPR-Cas9: A New Era for Microbial Systems

Über Autor(innen)

Srivastava, Akanksha
Dr. Akanksha Srivastava is currently a Research Scientist in the Department of Microbiology, Institute of Medical Science, Banaras Hindu University, Varanasi, India. She earned her PhD in Life Science from the Academy of Scientific and Industrial Research (AcSIR), CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow. Her expertise is in microbiology, fermentation technology, and virology. She was a recipient of the Young Women Scientist fellowship award from DST in the WOS-A scheme and previously received the ICMR- Research Associate and Senior Research Fellowship awards. She is a reviewer for several reputed international peer-reviewed journals. She has published numerous research papers in acclaimed journals, has authored one book, book chapters, as well as review articles. She was recognized for excellence in research by the Honorable Chief Minister of Uttar Pradesh, India, the SGBRD Society, and the SIEBS Society. Her international collaborations include researchers in Israel, United Kingdom, United States, and Finland.